Overview

  • Product nameRauwolscine hydrochloride
  • Description
    Potent α2 adrenergic antagonist
  • Alternative names
    • alpha-yohimbine
    • corynanthidine
    • isoyohimbine
  • Biological descriptionPotent α2 adrenergic antagonist (Ki values are 3.5 (α2A), 0.37 (α2B), 0.13 (α2C) and 63.6 nM (α2D)). Partial 5-HT receptor antagonist (Ki = 14-40 nM). Centrally active following systemic administration.
  • Purity> 99%

Properties

    References for Rauwolscine hydrochloride (ab120875)

    This product has been referenced in:
    • Naselsky DP  et al. Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology. J Pharmacol Exp Ther 298:219-25 (2001). Read more (PubMed: 11408545) »
    • Wainscott DB  et al. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor. Naunyn Schmiedebergs Arch Pharmacol 357:17-24 (1998). Read more (PubMed: 9459568) »
    • Bylund DB  et al. Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1-5 (1992). Read more (PubMed: 1353247) »
    • Weinshank RL  et al. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta. Proc Natl Acad Sci U S A 89:3630-4 (1992). Read more (PubMed: 1565658) »
    • Timmermans PB  et al. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors. J Pharmacol Exp Ther 228:739-48 (1984). Read more (PubMed: 6142941) »
    • KOHLI JD & DE NN Pharmacological action of rauwolscine. Nature 177:1182 (1956). Read more (PubMed: 13334509) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120875.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"